focus -WSS

focus

author：focus 2025-09-30 22:05:19 - browse：168

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Will an HIV vaccine ever be a reality?

explore

focus

WSS

Health insurers' Q3 question: how much care are people getting?

6 solutions to address cancer drug shortages and others

Lawsuit highlights wrinkle for disputes over surprise medical bills

Experts study whether long Covid risk adds up with each reinfection

Why is France rioting? What to know about the fatal police shooting of Nahel M

6 solutions to address cancer drug shortages and others

hotspot

focus

hotspot

In Memoriam: Notable people who died in 2023

Congress extends some pandemic preparedness programs

Duchenne breakthrough therapy leaves behind pioneering families

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Peter Hotez and the public health issue of online harassment

WHO recommends second malaria vaccine

BioMarin wins approval for gene therapy to treat hemophilia A

Can food be medicine? And other questions about a new push

Wildfire smoke exposes gaps in outdoor worker protections

What we owe ALS patients — and why one company fell short

hotspot

Connecting traumatic brain injury and domestic violence

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Health insurers' Q3 question: how much care are people getting?

WHO recommends second malaria vaccine

Doctor appointment wait times are getting worse

focus

explore

focus

hotspot